The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Emerging links between type 2 diabetes and Alzheimer's disease
Open accessAbstract
Type 2 diabetes mellitus and Alzheimer's disease are both associated with increasing age, and each increases the risk of development of the other. Epidemiological, clinical, biochemical and imaging studies have shown that elevated glucose levels and diabetes are associated with cognitive dysfunction, the most prevalent cause of which is Alzheimer's disease. Cross sectional studies have clearly shown such an association, whereas longitudinal studies are equivocal, reflecting the many complex ways in which the two interact. Despite the dichotomy, common risk and etiological factors (obesity, dyslipidemia, insulin resistance, and sedentary habits) are recognized; correction of these by lifestyle changes and pharmacological agents can be expected to prevent or retard the progression of both diseases. Common pathogenic factors in both conditions span a broad sweep including chronic hyperglycemia per se, hyperinsulinemia, insulin resistance, acute hypoglycemic episodes, especially in the elderly, microvascular disease, fibrillar deposits (in brain in Alzheimer's disease and in pancreas in type 2 diabetes), altered insulin processing, inflammation, obesity, dyslipidemia, altered levels of insulin like growth factor and occurrence of variant forms of the protein butyrylcholinesterase. Of interest not only do lifestyle measures have a protective effect against the development of cognitive impairment due to Alzheimer's disease, but so do some of the pharmacological agents used in the treatment of diabetes such as insulin (especially when delivered intranasally), metformin, peroxisome proliferator-activated receptors γ agonists, glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors. Diabetes must be recognized as a risk for development of Alzheimer's disease; clinicians must ensure preventive care be given to control and postpone both conditions, and to identify cognitive impairment early to manage it appropriately.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AD patients are predisposed to some complications including increased oxidative stress (Sultana et al., 2011), morbidity, mortality (Schelke et al., 2016), microvascular disease, dyslipidemia, and insulin resistance (Sridhar et al., 2015).”
From Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial (2016) · cites this paper as Sridhar et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle
Kang, J.-E., Lim, M. M., Bateman, R. J., Lee, J. J., Smyth, L. P., Cirrito, J. R., Fujiki, N., Nishino, S., & Holtzman, D. M. (2009) · Science · doi:10.1126/science.1180962 · Cited by 1,565
Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus
Whitmer, R. A. (2009) · JAMA · doi:10.1001/jama.2009.460 · Cited by 1,128
Inestrosa, N. C., Alvarez, A. R., Pérez, C. A., Moreno, R. D., Vicente, M., Linker, C., Casanueva, O. I., Soto, C. A., & Garrido, J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80108-7 · Cited by 1,117
Diabetes and cognitive dysfunction
McCrimmon, R. J., Ryan, C. M., & Frier, B. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60360-2 · Cited by 934
Glucose Levels and Risk of Dementia
Crane, P. K., Walker, R., Hubbard, R. A., Li, G., Nathan, D. M., Zheng, H., Haneuse, S., Craft, S., Montine, T. J., Kahn, S. E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215740 · Cited by 929
on behalf of the ICMR–INDIAB Collaborative Study Group, Anjana, R. M., Pradeepa, R., Deepa, M., Datta, M., Sudha, V., Ranjit Unnikrishnan, I., Bhansali, A., Joshi, S., Joshi, P. P., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2291-5 · Cited by 924
Yoshitake, T., Kiyohara, Y., Kato, I., Ohmura, T., Iwamoto, H., Nakayama, K., Ohmori, S., Nomiyama, K., Kawano, H., Ueda, K., et al. (1995) · Neurology · doi:10.1212/wnl.45.6.1161 · Cited by 829
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–123 of 123
Wei, K. W. (2016) · eScholarship (California Digital Library)
Kurudenkandy, F. R. (2016) · Figshare
A Probe into the Parallel Elements of Diabetes Mellitus and Alzheimer’s Disease
Roobini, M. S., & Lakshmi, M. N. (2020) · Journal of Computational and Theoretical Nanoscience · doi:10.1166/jctn.2020.9238
Qi, B., Hu, L., Zhu, L., Shang, L., Sheng, L., Wang, X., Liu, N., Wen, N., Yu, X., Wang, Q., et al. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01161-9
Retracted[Increase in resistance to UV-light in E. coli bearing the Hly plasmid resistance].
Bryzgunova, N. I., Tb, L., Kd, P., & Vg, L. (1975) · PubMed
Monteiro, E. G. A., Rezende, L. F. A., de Oliveira, L. B., da Silva, F. Q., Silva, P. M., Pinto, N. J. S., Leal, M. A. M., Silva, C. F. P., de Souza, M. C., Braz, L. D. S., et al. (2022) · doi:10.22533/at.ed.8142229065
da Silva, C. E., & Nardi, S. C. D. S. (2022) · doi:10.22533/at.ed.81422290614
CRIANÇAS DIANTE DA MORTE:ANÁLISE DE LIVROS INFANTIS
Costa, L. R., & Martins, A. M. (2022) · doi:10.22533/at.ed.81422290612
ATRIBUIÇÕES DO PSICÓLOGO ESCOLAR COM FOCO NA ORIENTAÇÃO PROFISSIONAL
Cibien, A. D. N., Regason, Q. P., Souza, R. P., Collares, L. A., Nardi, S. C. D. S., Rosa, A. Q., & Torma, S. M. T. (2022) · doi:10.22533/at.ed.8142229064
INFLUÊNCIA DAS PRÁTICAS PARENTAIS NO DESENVOLVIMENTO INFANTIL
de Araújo, I. L. O., Santos, J. S., & Araújo, V. (2022) · doi:10.22533/at.ed.8142229067
A PASSAGEM ADOLESCENTE EM D.W. WINNICOTT
Pinto, É. M. F. (2022) · doi:10.22533/at.ed.8142229061
PRIORIDADE HUMANITÁRIA-ECONÔMICA NA PANDEMIA DA COVID-19: VALIDAÇÃO DE UMA ESCALA PSICOMÉTRICA
Albuquerque, L. F., dos Santos, M. C., Cabral, S. F. M., Pessoa, T. E. G., & Gouveia, V. V. (2022) · doi:10.22533/at.ed.8142229068
COVID-19: QUAL É O IMPACTO NO BEM-ESTAR PSICOLÓGICO DOS PROFISSIONAIS DA SAÚDE?
Bernardo, A. C. F., & Bach, S. D. L. (2022) · doi:10.22533/at.ed.81422290610
A IMPORTÂNCIA DA HUMANIZAÇÃO DO APARATO JUDICIÁRIO NAS QUESTÕES DE DIREITOS DAS MULHERES
de Lima, G. B., & Yazawa, T. (2022) · doi:10.22533/at.ed.81422290615
Fernandes, D. D. O., Júnior, P. C. B., & Lyra, F. A. (2022) · doi:10.22533/at.ed.81422290618
A EXPERIÊNCIA DO EXERCÍCIO DA PARENTALIDADE: UMA ARTICULAÇÃO COM A GESTALT-TERAPIA
de Lucena, A. L., & Belmino, M. C. D. B. (2022) · doi:10.22533/at.ed.8142229062
Molecular Basis of Role of Insulin Resistance in Pathophysiology of Alzheimer’s Disease
Gupta, A. (2022) · International Journal of Health Sciences and Pharmacy · doi:10.47992/ijhsp.2581.6411.0094
Monday, A. B. (2023) · Journal of Food Technology & Nutrition Sciences · doi:10.47363/jftns/2023(5)155
The ER chaperone, BIP protects Microglial cells from ER stress-mediated Apoptosis in HyperglycemiaPreprint
James, A. W., Bahader, G. A., Albassan, M., & Shah, Z. A. (2023) · Research Square · doi:10.21203/rs.3.rs-2626070/v1
Tovar, M. C. G., Torres‐Salinas, D., & Baker, K. (2025) · Cureus · doi:10.7759/cureus.86086
“In addition, comorbidities have been suggested to influence the diagnosis and severity of AD [1,3].”
InfluentialMobilisation de l'acide arachidonique et sensibilité au peptide ß-amyloïde
Thomas, M. H. (2015) · theses.fr (ABES) · doi:10.70675/904987d5zc8c8z4104z95dfz2f7e680d8be3
Zhang, Z.-J., Wang, J.-X., Wang, C.-X., & He, L. (2026) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.117029
Sarkar, R., Kabra, A., Saeedan, A. S., & Ansari, M. N. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.6c00440
Metadata
- Authors
- Sridhar, G. R.
- Corresponding author
- Sridhar, Gumpeny R
- ORCID
- Sridhar, Gumpeny R
- Venue
- World Journal of Diabetes
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2015
- Volume
- 6
- Issue
- 5
- Pages
- 744
- ISSN
- 1948-9358 (ISSN-L)
- PMC
- PMC4458503
- OpenAlex
- W563315964
- Cited by
- 123
- References
- 65
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 5 · 2023: 8 · 2022: 19 · 2021: 7 · 2020: 14 · 2019: 14 · 2018: 11 · 2017: 12 · 2016: 13 · 2015: 8
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- Locations
- World Journal of Diabetes (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, Alzheimer's disease, cognitive impairment, hyperglycemia, insulin resistance, hyperinsulinemia, obesity, dyslipidemia, sedentary lifestyle, insulin-like growth factor, butyrylcholinesterase, insulin therapy, metformin, PPARγ agonists, GLP-1 receptor agonists, DPP-4 inhibitors, dementia prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
